<?xml version="1.0" encoding="UTF-8"?>
<table id="PMC6835697/table_7" xmlns="http://www.w3.org/1999/xhtml">
 <caption>
  <label>Table 7</label>
  <p>In vivo anti-HIV-1 activity of GRFT in animal models.</p>
 </caption>
 <thead>
  <tr>
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" id="0-0-.">Models Used</th>
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" id="0-1-.">Dose Tested</th>
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" id="0-2-.">Effects of GRFT</th>
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" id="0-3-.">Ref.</th>
  </tr>
 </thead>
 <tbody>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Guinea pig 
    <br/>BALB/c mice 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Single 50 mg/kg and 10 daily subcutaneous injections of 10 mg/kg.</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Retention of antiviral activity in serum</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[ 
    <a rid="B41-marinedrugs-17-00567" ref-type="bibr">41</a>] 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sprague Dawley (SD) rats</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A single dose of 10 mg/mL intravenously or subcutaneously. 
    <br/>Ten 40 mg/kg doses for 10 days. 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Neutralization activity found in fecal extracts</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[ 
    <a rid="B46-marinedrugs-17-00567" ref-type="bibr">46</a>] 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Humanized bone marrow-liver-thymus mice</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10 
    <sup>8</sup> GRFT-expressing recombinant 
    <i>C. crescentus</i> intravaginally. 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Protection against HIV-1 infection</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[ 
    <a rid="B47-marinedrugs-17-00567" ref-type="bibr">47</a>] 
   </td>
  </tr>
 </tbody>
</table>
